Nomura Asset Management’s Regenxbio RGNX Stock Holding History

Nomura Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,000	Closed	-$410K	–	957
2019 Q4	$410K	Hold	10,000	–	–	﹤0.01%	883
2019 Q3	$356K	Hold	10,000	–	–	﹤0.01%	892
2019 Q2	$514K	Hold	10,000	–	–	0.01%	867
2019 Q1	$573K	Hold	10,000	–	–	0.01%	834
2018 Q4	$420K	Hold	10,000	–	–	﹤0.01%	831
2018 Q3	$755K	Hold	10,000	–	–	0.01%	795
2018 Q2	$718K	Hold	10,000	–	–	0.01%	815
2018 Q1	$299K	Hold	10,000	–	–	﹤0.01%	890
2017 Q4	$333K	Buy	+10,000	New	+$301K	﹤0.01%	863

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Nomura Asset Management's RGNX Position: Q1 2020 in Review

Nomura Asset Management sold out of Regenxbio (RGNX) in Q1 2020, closing a stake of 10,000 shares — an estimated $410K sold.

Nomura Asset Management first reported a position in RGNX in Q4 2017 and held it in 9 quarters. The position peaked at $755K in Q3 2018. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

Nomura Asset Management reported no remaining Regenxbio position as of Q1 2020 after selling out during the quarter.
Nomura Asset Management sold 10,000 Regenxbio shares in Q1 2020, an estimated $410K.
Nomura Asset Management first reported a position in Regenxbio in Q4 2017 and held it in 9 quarters.
Nomura Asset Management's Regenxbio position peaked at $755K in Q3 2018.
170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on Nomura Asset Management's 13F filing for Q1 2020, filed 14 May 2020.